Nevro stock: buy or sell?

NVRO stock price: $135.59 -2.45% At close on February 27th, 2020

Updated on:
February 27th, 2020


After topping to all time highs yesterday, Nevro eased -2.45% to $135.59.

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally.

Should I buy Nevro stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

Currently, Nevro stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Nevro stock a buy?

Financial institutions and banks publish stock ratings everyday. Unfortunately, we couldn't find any rating for NVRO stock for the last month.

Nevro stock analysis

Daily outlook

Nevro eased -2.45% to $135.59 after reaching all time highs yesterday.

After reaching all time highs yesterday, Nevro eased -2.45% today to $135.59. Yesterday, NVRO hit new all time highs, pushing higher previous ATH of $145.56 recorded on February/19. New ATHs are usual entry points for many trading setups as there aren't higher resistences. Since last November when NVRO stock price broke up the SMA50d line, it gained $50.34 (59.05%).

NVRO stock chart (daily)

Weekly outlook

Nevro closed this week at $135.59 after marking a new all time high ($148.05) even it couldn't close with gains and slightly fell a tragic -1.92%. Late January NVRO boosted an amazing 6.06% in just one week.

NVRO shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom by mid January, NVRO climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up by mid May 2019, NVRO price climbed $75.39 per share (125.23%). Since mid March 2019 when NVRO stock price broke up the SMA40w line, it gained $91.90 (210.35%).

NVRO stock chart (weekly)

Nevro stock price history

Nevro IPO was on November 6th, 2014 at $23.40 per share1. Since then, NVRO stock surged a 479.40%, with an average of 95.90% per year. If you had invested $1,000 in Nevro stock in 2014, it would worth $4,794.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Nevro stock historical price chart

NVRO stock reached all-time highs yesterday with a price of $148.05.

Nevro stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' NVRO stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price prediction for Nevro stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, Nevro presented its financial report, posting an exceptional growth for the Earnings per Share (EPS). Experts were expecting $-0.17 per share, but Nevro posted $-0.32.
NVRO earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual sales report draw a super good growth of 18.56% to $387.29 M dollars. In contrary, its profit margin (compared to sales) decreased to -12.70%, that is $-49.21 million.

NVRO annual Sales and Income evolution
2013$24 M-$-26.17 M-111.4%-
2014$33 M38.61%$-30.68 M-94.2%17.23%
2015$70 M113.69%$-67.43 M-96.9%119.79%
2016$229 M228.28%$-31.78 M-13.9%-52.87%
2017$327 M42.96%$-36.66 M-11.2%15.36%
2018$387 M18.56%$-49.21 M-12.7%34.23%

Quarterly financial results

Nevro posted $107.94 million in sales for 2018-Q4, a 12.88% up compared to previous quarter. Reported quarter earnings marked $-9.61 million with a profit margin of -8.90%. Profit margin inched a 2.88% compared to previous quarter when profit margin was -11.78%. When comparing revenues to same quarter last year, Nevro sales marked a brilliant increase and boosted a 10.19%.
NVRO quarterly Sales and Income evolution
2017-Q1$68 M-$-14.51 M-21.2%-
2017-Q2$78 M14.00%$-11.61 M-14.9%-19.99%
2017-Q3$82 M5.43%$-6.23 M-7.6%-46.34%
2017-Q4$98 M19.10%$-4.31 M-4.4%-30.80%
2018-Q1$88 M-10.54%$-17.71 M-20.2%310.88%
2018-Q2$96 M9.64%$-10.62 M-11.1%-40.04%
2018-Q3$96 M-0.47%$-11.27 M-11.8%6.07%
2018-Q4$108 M12.88%$-9.61 M-8.9%-14.72%

Nevro ownership

When you are planning to buy shares of a company, it's worth to have a look its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Nevro, 2.50% of all outstanding shares are owned by its staff.

Bearish positions for NVRO stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Nevro:

Market cap$4.2 B
Total shares31.0 M
Float shares28.3 M
  - Institutional holdings (%)111.2%
  - Insider holdings (%)2.5%
Shares in short selling0.0%

Nevro summary

Thursday, February 27th, 2020
Day range$133.64 - $140.25
Previous close$139.00
Session gain-2.45%
Average true range$5.01
50d mov avg$127.01
100d mov avg$111.82
200d mov avg$91.53
Daily pattern
Weekly pattern lb03c

Nevro performance

To better understand Nevro performance you must becnhmark its gains with other related stocks in same sector or industry. For Nevro, the benchmark is made against .

Nevro competitors

Unfortunately, we could not find any public company that could be defined as Nevro competitor. This doesn't mean Nevro does not have any competitor in the market, it's just we could not detected it.